GPRIX | RSEBX | GPRIX / RSEBX | |
Total Expense Ratio | 1.25 | 1.45 | 86% |
Annual Report Gross Expense Ratio | 1.30 | 1.45 | 90% |
Fund Existence | 12 years | 11 years | - |
Gain YTD | 8.469 | 8.158 | 104% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 250 | 400% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 128M | 79B | 0% |
Annual Yield % from dividends | 1.76 | 0.23 | 757% |
Returns for 1 year | 2.35 | 5.44 | 43% |
Returns for 3 years | 19.02 | 32.82 | 58% |
Returns for 5 years | -0.62 | 15.89 | -4% |
Returns for 10 years | 27.68 | 38.64 | 72% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PMDHX | 19.07 | 0.25 | +1.33% |
Principal Small-MidCap Dividend Inc R6 | |||
TNVIX | 17.97 | 0.16 | +0.92% |
1290 GAMCO Small/Mid Cap Value I | |||
EMQIX | 9.11 | 0.04 | +0.44% |
Ashmore Emerging Markets Active Eq Instl | |||
QTELX | 12.06 | 0.04 | +0.33% |
AQR Emerging Multi-Style II I | |||
SHSCX | 44.76 | -4.26 | -8.69% |
BlackRock Health Sciences Opps Inv C |